X4 Pharmaceuticals (XFOR) Other Non Operating Income (2017 - 2025)
X4 Pharmaceuticals (XFOR) posted Other Non Operating Income of -$676000.0 for Q3 2025, down 125.59% on a QoQ basis from $2.6 million in Q2 2025, and down 399.12% year-over-year from $226000.0 in Q3 2024.
X4 Pharmaceuticals (XFOR) Other Non Operating Income (2017 - 2025) Analysis & Trends
X4 Pharmaceuticals' Other Non Operating Income history runs 9 years deep, the most recent figure standing at -$676000.0 for Q3 2025.
- Quarterly Other Non Operating Income fell 399.12% year-over-year to -$676000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $12.8 million (up 1031.39% YoY) and the FY2025 annual result came in at $12.8 million, up 3748.8% from the prior year.
- Other Non Operating Income was -$676000.0 for Q3 2025 at X4 Pharmaceuticals, down from $2.6 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $10.8 million in Q1 2025 and bottomed at -$676000.0 in Q3 2025.
- A 5-year average of $1.2 million and a median of $123000.0 in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income slumped 495.95% — and 2025, when it soared 10214.29%.
- X4 Pharmaceuticals' Other Non Operating Income stood at $103000.0 in 2021, then jumped by 1978.64% to $2.1 million in 2022, then soared by 214.43% to $6.7 million in 2023, then sank by 89.6% to $700000.0 in 2024, then slumped by 196.57% to -$676000.0 in 2025.
- Business Quant data shows XFOR's Other Non Operating Income at -$676000.0 in Q3 2025, $2.6 million in Q2 2025, and $10.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | X4 Pharmaceuticals | 167.90 Mn | -49.15 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -676,000.00 |
| Jun 30, 2025 | 2.64 Mn |
| Mar 31, 2025 | 10.83 Mn |
| Dec 31, 2024 | 700,000.00 |
| Sep 30, 2024 | 226,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 105,000.00 |
| Dec 31, 2023 | 6.73 Mn |
| Sep 30, 2023 | 17,000.00 |
| Jun 30, 2023 | 202,000.00 |
| Mar 31, 2023 | 123,000.00 |
| Dec 31, 2022 | 2.14 Mn |
| Sep 30, 2022 | -441,000.00 |
| Jun 30, 2022 | -59,000.00 |
| Mar 31, 2022 | 60,000.00 |
| Dec 31, 2021 | 103,000.00 |
| Sep 30, 2021 | -74,000.00 |
| Jun 30, 2021 | 210,000.00 |
| Mar 31, 2021 | 186,000.00 |
| Dec 31, 2020 | -656,000.00 |